PT Millennium Pharmacon International Tbk (IDX:SDPC)
Indonesia flag Indonesia · Delayed Price · Currency is IDR
190.00
+10.00 (5.56%)
May 26, 2026, 4:00 PM WIB

IDX:SDPC Balance Sheet

Millions IDR. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
39,84362,84353,47358,90025,66847,362
Cash & Short-Term Investments
39,84362,84353,47358,90025,66847,362
Cash Growth
-32.74%17.52%-9.21%129.46%-45.80%-1.44%
Accounts Receivable
889,013812,002731,940659,684545,672440,453
Other Receivables
30,30321,7419,65423,14922,82220,622
Receivables
919,316833,742741,593682,833568,494461,074
Inventory
600,126609,092567,732535,874538,433453,301
Prepaid Expenses
215,8334,0855,3013,4321,9731,091
Other Current Assets
2,365209,179195,694166,613124,390107,476
Total Current Assets
1,777,4841,718,9421,563,7941,447,6521,258,9591,070,305
Property, Plant & Equipment
135,781138,528111,417112,59446,69542,287
Long-Term Investments
18,58618,58622,50833,30054,00054,000
Other Intangible Assets
6,6346,9957,7799,1428,737-
Long-Term Deferred Tax Assets
27,51227,35417,05616,57614,48917,309
Other Long-Term Assets
49,05150,31449,30320,41818,62522,485
Total Assets
2,015,0471,960,7201,771,8571,639,6821,401,5051,206,386
Accounts Payable
683,307694,449527,590545,863468,604413,383
Accrued Expenses
30,11424,48622,60425,87320,96113,441
Short-Term Debt
797,662749,562798,202665,059620,324514,497
Current Portion of Long-Term Debt
-6,4245,009---
Current Portion of Leases
314.35458.7-358.33468432
Current Income Taxes Payable
-240.46114.471,4241,429453.33
Other Current Liabilities
90,79480,24959,89748,4221,252382.8
Total Current Liabilities
1,602,1911,555,8711,413,4171,287,0011,113,038942,589
Long-Term Debt
51,49653,29643,31144,000--
Long-Term Leases
59.9659.96-918.221,5101,798
Pension & Post-Retirement Benefits
35,79336,09032,63230,05028,04625,019
Total Liabilities
1,689,5401,645,3171,489,3601,361,9691,142,595969,406
Common Stock
127,400127,400127,400127,400127,400127,400
Additional Paid-In Capital
2,3102,3102,3102,3102,3102,310
Retained Earnings
219,240209,135173,167159,951129,200107,270
Comprehensive Income & Other
-23,420-23,420-20,361-11,943--
Total Common Equity
325,529315,424282,515277,717258,910236,979
Minority Interest
-21.83-21.23-18.57-3.83--
Shareholders' Equity
325,507315,403282,497277,713258,910236,979
Total Liabilities & Equity
2,015,0471,960,7201,771,8571,639,6821,401,5051,206,386
Total Debt
849,532809,802846,522710,336622,302516,727
Net Cash (Debt)
-809,689-746,959-793,049-651,436-596,633-469,365
Net Cash Per Share
-635.54-586.31-622.49-511.33-468.32-368.42
Filing Date Shares Outstanding
1,2741,2741,2741,2741,2741,274
Total Common Shares Outstanding
1,2741,2741,2741,2741,2741,274
Working Capital
175,293163,071150,377160,652145,920127,716
Book Value Per Share
255.52247.59221.75217.99203.23186.01
Tangible Book Value
318,895308,429274,737268,575250,173236,979
Tangible Book Value Per Share
250.31242.10215.65210.81196.37186.01
Land
-47,96747,96747,9674,8954,895
Buildings
-19,69110,5156,2787,4128,084
Machinery
-48,51747,23645,68242,95641,061
Construction In Progress
-32,82512,39311,819-637.58
Leasehold Improvements
-24,97221,45516,09012,04813,825
Source: S&P Global Market Intelligence. Standard template. Financial Sources.